West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc.
Your view on WST
Overview
What the company does, where it operates, and who runs it.
About West Pharmaceutical Services, Inc.
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- CEO
- Eric M. Green
- Headquarters
- 530 Herman O. West Drive, Exton, PA, US
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- CEO
- Eric M. Green
- Headquarters
- 530 Herman O. West Drive, Exton, PA, US
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.
The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components.
It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support.
This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.
Stock Data
Price chart, volume, and trading data.
What moved it
FRC Fair Value Algorithm
What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.
About this section
Fair value for West Pharmaceutical Services, Inc. from FRC's valuation model, read against the market price. WST last traded at $417.80, 46.5× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for West Pharmaceutical Services, Inc.. Starting points for West Pharmaceutical Services, Inc.: P/E 46.5, EPS $9.08, beta 1.14 — an Medical - Instruments & Supplies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for West Pharmaceutical Services, Inc.. West Pharmaceutical Services, Inc. paid $0.92 per share over the last year — a 0.2% yield at the current $417.80 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for West Pharmaceutical Services, Inc.. Trailing twelve-month EPS for West Pharmaceutical Services, Inc. stands at $9.08. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.
Current price
—
live quote
Analysts' target
$413.38
average of 8 firms, last 12 months
Analyst Ratings
- Strong Buy0
- Buy8
- Hold0
- Sell0
- Strong Sell0
Earnings Estimate
| EPS | Current QtrDec 2026 | Next QtrMar 2027 | Current YearFY Dec 2026 | Next YearFY Dec 2027 |
|---|---|---|---|---|
| Avg. estimate | $2.29 | $2.36 | $9.49 | $10.36 |
| Low estimate | $2.25 | $2.21 | $8.99 | $9.51 |
| High estimate | $2.31 | $2.44 | $9.62 | $10.82 |
| No. of analysts | 9 | 4 | 10 | 10 |
| Year-ago EPS | $2.04 | $2.13 | $6.80 | — |
| Growth | +12.3% | +10.6% | +39.6% | — |
Revenue Estimate
| Revenue | Current QtrDec 2026 | Next QtrMar 2027 | Current YearFY Dec 2026 | Next YearFY Dec 2027 |
|---|---|---|---|---|
| Avg. estimate | $825.22M | $859.36M | $3.42B | $3.62B |
| Low estimate | $821.74M | $849.87M | $3.38B | $3.52B |
| High estimate | $829.25M | $873.96M | $3.44B | $3.71B |
| No. of analysts | 8 | 4 | 12 | 12 |
| Year-ago revenue | $805.00M | $844.90M | $3.07B | — |
| Growth | +2.5% | +1.7% | +11.2% | — |
Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep from StreetInsider, Benzinga; as of Nov 18, 2026. Not FRC research or a recommendation.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for West Pharmaceutical Services, Inc.. West Pharmaceutical Services, Inc. has reported as a listed company since 1980. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Peer companies
Market cap
- ATRAptarGroup, Inc.Medical - Instruments & Supplies$9.1B
- BLFSBioLife Solutions, Inc.Medical - Instruments & Supplies$1.9B
- ICUIICU Medical, Inc.Medical - Instruments & Supplies$4.5B
- SDMHFSartorius Stedim Biotech S.A.Medical - Instruments & Supplies$21.2B
- SOAGYSartorius AGMedical - Instruments & Supplies$82.3B
- STVNStevanato Group S.p.A.Medical - Instruments & Supplies$4.2B
More Medical - Instruments & Supplies companies
- STAASTAAR Surgical CompanyNASDAQ$1.3B
- STSSSharps Technology, Inc.NASDAQ$54M
- STXSStereotaxis, Inc.AMEX$80M
- SUVPFSartorius AGOTC$18.7B
- SVSOSheerVision, Inc.OTC$2,551
- TCGGYTecan Group AGOTC$2.3B
- TCHBFTecan Group AGOTC$2.2B
- TDVXFTobii Dynavox AB (publ)OTC$982M
- TFXTeleflex IncorporatedNYSE$6.2B
- TGLVYTop Glove Corporation Bhd.OTC$1.1B
- TRJ.AXTrajan Group Holdings LimitedASX
ETFs holding West Pharmaceutical Services, Inc.
% of the fund
- VOOVanguard S&P 500 ETF$1.0T in assets0.04%
- VTIVanguard Total Stock Market ETF$689.2B in assets0.04%
- VOVanguard Mid-Cap ETF$103.4B in assets0.28%
- VUGVanguard Growth ETF$232.9B in assets0.11%
- FMTMMarketDesk Focused U.S. Momentum ETF$268M in assets3.48%
- BASGBrown Advisory Sustainable Growth ETF$507M in assets3.40%
- KNGFT Cboe Vest S&P 500 Dividend Aristocrats Target Income ETF$3.5B in assets1.50%
- NOBLProShares - S&P 500 Dividend Aristocrats ETF$12.1B in assets1.48%
Largest holders first, then the funds most concentrated in WST.
Institutional Ownership
Which funds and firms own the stock.
About this section
Which institutions hold West Pharmaceutical Services, Inc., and how their positions are changing. At a $29.10B market value, institutional positions materially move West Pharmaceutical Services, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by West Pharmaceutical Services, Inc. executives and directors. Shares of West Pharmaceutical Services, Inc. have traded between $187.43 and $348.90 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
About this section
U.S. Senate disclosures naming West Pharmaceutical Services, Inc.. West Pharmaceutical Services, Inc. is a $29.10B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.
House Trading
U.S. Representative disclosures filed under the STOCK Act.
About this section
U.S. House of Representatives disclosures naming West Pharmaceutical Services, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for West Pharmaceutical Services, Inc.. Coverage tracks West Pharmaceutical Services, Inc. within Medical - Instruments & Supplies (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of West Pharmaceutical Services, Inc.